Agfa HealthCare to Launch Latest Version of IMPAX for Nuclear Medicine

Agfa HealthCareAgfa HealthCare announces that it will launch the latest version of its IMPAX for Nuclear Medicine solution at the 2012 Congress of the European Association of Nuclear Medicine (EANM) in Milan, Italy. Delivering the benefits of integrated care to the nuclear medicine department, this solution supports the patient's entire exam flow. The new version offers enhanced integration and refined in-depth clinical content, for improved usability, workflow and productivity.

All the images and data the clinician needs, on one workstation
IMPAX for Nuclear Medicine fully integrates the department's workflow, bringing together images and data from a wide range of modalities and departments into one IT platform. Users can process, read and report all nuclear medicine, SPECT, PET, and multi-modality images with just the click of a button, from a single workstation.

Built on advanced, proven IMPAX PACS
IMPAX for Nuclear Medicine is built on one of the most advanced Picture Archiving and Communication Systems (PACS). "IMPAX for Nuclear Medicine continues to offer the nuclear medicine department all the benefits of integrated care, and in this advanced version of the solution we have further improved integration and clinical content," comments Erik Gielen, EMEA Business Manager, Agfa HealthCare. "From start to finish, it supports the patient's complete exam flow, while also improving inter-departmental communication."

"Oasis for IMPAX, one of the components of the IMPAX for Nuclear Medicine solution and developed in cooperation with Segami Corp., adds a fully featured nuclear medicine image processing and viewing platform to the IMPAX workstation," said Dr. Léonne Prompers, nuclear medicine physician, University Hospital of Maastricht, the Netherlands. "We no longer have to switch between workstations, or manually synchronize patient study lists. We can now read and report all studies from the IMPAX workstation resulting in improved workflow and increased user convenience."

Visit us at EANM from 27-31 October, Milan, Italy, Booth #603a and find out more about IMPAX for Nuclear Medicine.

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...